D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$826M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
Pinduoduo
PDD
|
+$305M |
| 4 |
Intel
INTC
|
+$274M |
| 5 |
Apple
AAPL
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$382M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$298M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 4 |
Procter & Gamble
PG
|
+$260M |
| 5 |
Meta Platforms (Facebook)
META
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.32% |
| 2 | Healthcare | 8.96% |
| 3 | Financials | 7.81% |
| 4 | Consumer Discretionary | 7.49% |
| 5 | Industrials | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EB
3476
DELISTED
Eventbrite
EB
| $767K | ﹤0.01% |
130,953
-37,710
| -22% | -$247K |
|
3477
CGI
GIB
$15.4B
| $767K | ﹤0.01% |
8,900
-5,900
| -40% | -$486K |
|
3478
Kadant
KAI
$3.95B
| $766K | ﹤0.01% |
4,313
+1,197
| +38% | +$213K |
|
3479
Zai Lab
ZLAB
$2.36B
| $765K | ﹤0.01% |
24,913
-200
| -0.8% | -$6.31K |
|
3480
WPP
WPP
$5.6B
| $764K | ﹤0.01% |
15,549
-15,965
| -51% | -$760K |
|
3481
Walker & Dunlop
WD
$1.52B
| $764K | ﹤0.01% |
+9,735
| New | +$818K |
|
|
SAGE
3482
PUT
DELISTED
Sage Therapeutics
SAGE
| $763K | ﹤0.01% |
20,000
| – | – |
|
|
SGFY
3483
DELISTED
Signify Health, Inc.
SGFY
| $760K | ﹤0.01% |
26,529
-18,802
| -41% | -$543K |
|
3484
UBS Group
UBS
$173B
| $758K | ﹤0.01% |
40,588
+27,288
| +205% | +$464K |
|
3485
PUT
Bausch Health
BHC
$2.21B
| $754K | ﹤0.01% |
+120,000
| New | +$838K |
|
3486
PUT
Fidelity National Financial
FNF
$14.1B
| $752K | ﹤0.01% |
+20,000
| New | +$751K |
|
3487
Fabrinet
FN
$19.5B
| $751K | ﹤0.01% |
5,858
-7,745
| -57% | -$924K |
|
3488
CALL
Tandem Diabetes Care
TNDM
$1.29B
| $751K | ﹤0.01% |
16,700
| – | – |
|
3489
OFG Bancorp
OFG
$2.24B
| $749K | ﹤0.01% |
27,181
-8,932
| -25% | -$245K |
|
|
PENG
3490
PUT
Penguin Solutions Inc
PENG
$2.88B
| $745K | ﹤0.01% |
+50,100
| New | +$766K |
|
3491
CALL
International Seaways
INSW
$4.61B
| $740K | ﹤0.01% |
+20,000
| New | +$809K |
|
3492
Liberty Latin America Class A
LILA
$1.75B
| $739K | ﹤0.01% |
144,559
+9,304
| +7% | +$47.5K |
|
3493
The Honest Company
HNST
$597M
| $737K | ﹤0.01% |
244,756
-236,262
| -49% | -$737K |
|
3494
CALL
Freshworks
FRSH
$3.2B
| $736K | ﹤0.01% |
50,000
| – | – |
|
|
PRTK
3495
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $734K | ﹤0.01% |
392,696
+83,132
| +27% | +$207K |
|
3496
Cal-Maine
CALM
$3.98B
| $734K | ﹤0.01% |
13,484
-30,496
| -69% | -$1.76M |
|
|
PMT
3497
PennyMac Mortgage Investment
PMT
$814M
| $733K | ﹤0.01% |
59,146
+1,517
| +3% | +$20.6K |
|
3498
Tootsie Roll Industries
TR
$2.99B
| $730K | ﹤0.01% |
19,310
-12,184
| -39% | -$444K |
|
3499
Equinox Gold
EQX
$8.48B
| $729K | ﹤0.01% |
+222,783
| New | +$768K |
|
|
NESR
3500
National Energy Services Reunited Corp
NESR
$2.91B
| $727K | ﹤0.01% |
104,752
+43,651
| +71% | +$289K |
|
Similar funds
D.E. Shaw & Co's Q4 2022 Portfolio in Review
As of Q4 2022, D.E. Shaw & Co held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
D.E. Shaw & Co's Q4 2022 filing shows 475 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- D.E. Shaw & Co's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
- D.E. Shaw & Co added most to Tesla in Q4 2022, an estimated $826M increase.
- D.E. Shaw & Co's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
- D.E. Shaw & Co fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
- D.E. Shaw & Co's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
- D.E. Shaw & Co opened 475 new positions and closed 783 in Q4 2022.
- D.E. Shaw & Co's portfolio value rose 8.1% quarter-over-quarter to $90.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.